STOCK TITAN

RXO: MFN agrees to vote for C.H. Robinson merger

MFN Partners’ voting commitment is subject to the agreement’s terms; the agreement also contains transfer restrictions and non-solicitation provisions.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

RXO, Inc. entered into a merger agreement on October 4, 2026, with C.H. Robinson Worldwide, Inc., Rover Merger Sub Inc. and Viking Logistics LLC. Under the two-step structure, Rover Merger Sub will merge into RXO, which will survive as a wholly owned subsidiary of C.H. Robinson; then RXO will merge into Viking Logistics, which will survive as a wholly owned subsidiary of C.H. Robinson, subject to the merger agreement’s terms and conditions.

In connection with the transaction, MFN Partners, LP agreed with C.H. Robinson to vote the RXO shares it is entitled to vote for adoption of the merger agreement and against any Acquisition Proposal, subject to the voting agreement’s terms. The partnership also agreed to transfer restrictions, subject to exceptions, and certain non-solicitation provisions. As of October 5, 2026, the reporting persons reported beneficial ownership of 32,687,269 shares, including 28,109,942 common shares held directly by the partnership and 4,577,327 shares issuable under warrants with a $0.01 exercise price. The warrants are exercisable only to the extent post-exercise beneficial ownership, together with attribution parties, does not exceed 19.9%. The reported 19.3% calculation uses 164,926,128 shares outstanding as of August 4, 2026, and gives effect to exercise of the warrants. Michael F. DeMichele and Farhad Nanji are managing members; Jonathan Reisman signed as an authorized person.

Beneficial ownership 32,687,269 shares Reported as of October 5, 2026; includes shares issuable upon exercise of warrants.
Common shares held directly by MFN Partners, LP 28,109,942 shares Component of the reporting persons’ beneficial ownership.
Shares issuable upon exercise of warrants 4,577,327 shares Included in the reporting persons’ beneficial ownership.
Warrant exercise price $0.01 per share Exercise price of the warrants.
Warrant beneficial ownership limit 19.9% Warrants are exercisable only to the extent post-exercise beneficial ownership with attribution parties does not exceed this amount.
Reported beneficial ownership percentage 19.3% Calculation gives effect to exercise of 4,577,327 warrants.
Shares outstanding used in percentage calculation 164,926,128 shares Outstanding as of August 4, 2026; the calculation gives effect to exercise of the warrants.
beneficial ownership financial
"aggregate amount beneficially owned by each reporting person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Voting Agreement regulatory
"entered into a voting and support agreement with Parent"
A voting agreement is a legally binding pact in which shareholders promise to cast their votes the same way on certain corporate matters, such as electing directors or approving a merger. It matters to investors because it changes who controls company decisions and makes outcomes more predictable—like a group of neighbors agreeing in advance to vote the same way on a community rule, it can strengthen or limit the influence of other shareholders and affect the company’s future direction.
Acquisition Proposal regulatory
"vote ... against any Acquisition Proposal"
A written offer from one company or investor to buy another company or its assets, outlining price, how the purchase would be funded, and key terms; think of it like a formal offer to buy a house. It matters to investors because the proposal can change share prices, alter ownership, affect future profits or debt levels, and may trigger votes, regulatory reviews, or competing bids that reshape the company’s value and strategy.
Warrants financial
"shares of Common Stock issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
non-solicitation provisions regulatory
"agreed to certain non-solicitation provisions"
A non-solicitation provision is a contract clause that prevents a party from actively trying to hire away a company’s employees or poach its customers and vendors for a set time. Think of it as a “no-steal” promise that protects relationships a business relies on; for investors it matters because such clauses can preserve workforce stability, revenue streams, and the value of an acquisition, while their absence or enforcement risk can affect future costs and growth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RXO shares do the MFN reporting persons beneficially own?

The reporting persons reported beneficial ownership of 32,687,269 shares as of October 5, 2026. That amount includes 28,109,942 common shares held directly by MFN Partners, LP and 4,577,327 shares issuable upon exercise of warrants.

What did MFN Partners agree to do in the RXO merger?

MFN Partners, LP agreed to vote the RXO shares it is entitled to vote for adoption of the merger agreement and against any Acquisition Proposal, subject to the voting agreement’s terms. The agreement also includes transfer restrictions subject to exceptions and certain non-solicitation provisions.

What limits apply to MFN Partners’ RXO warrants?

The 4,577,327 warrants have an exercise price of $0.01 per share. They are exercisable only to the extent that, following exercise, the reporting persons’ beneficial ownership, together with any attribution parties, does not exceed 19.9%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





74982T103

(CUSIP Number)
MFN Partners Management, LP
Attn: Jonathan Reisman, 222 Berkeley Street, 13th Floor
Boston, MA, 02116
(617) 443-2040

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/04/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of warrants with an exercise price of $0.01 which are only exercisable to the extent that following such exercise, the Reporting Persons' beneficial ownership of the Issuer, together with any attribution parties, does not exceed 19.9% ("Warrants"), and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D




Comment for Type of Reporting Person:
The securities represented in rows 8, 10 and 11 are comprised of (i) 4,577,327 shares of Common Stock issuable upon exercise of Warrants, and (ii) 28,109,942 shares of Common Stock. The number of shares of Common Stock outstanding for purposes of the percentage calculation in row 13 based on 164,926,128 shares of Common Stock outstanding as of August 4, 2026, as reported in the Issuer's quarterly report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026, and gives effect to the exercise of 4,577,327 Warrants.


SCHEDULE 13D


MFN Partners, LP
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
MFN Partners GP, LLC
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
MFN Partners Management, LP
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
MFN Partners Management, LLC
Signature:/s/ Jonathan Reisman
Name/Title:Jonathan Reisman, Authorized Person
Date:10/05/2026
Michael F. DeMichele
Signature:/s/ Michael F. DeMichele
Name/Title:Michael F. DeMichele, individually
Date:10/05/2026
Farhad Nanji
Signature:/s/ Farhad Nanji
Name/Title:Farhad Nanji, individually
Date:10/05/2026

Keep reading